v3.25.4
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Jan. 13, 2025
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Business combination related cost       $ 512,073     $ 527,145
Other receivables   $ 167,975   167,975 $ 167,975   138,046
Loss on issuance of forward purchase agreement $ 1,929,656 (1,929,656)    
Change in fair value of forward purchase agreement   (367,148) 756,006 756,005  
Forward purchase agreement liability   $ 1,173,651   1,173,651 $ 1,173,651  
Shenzhen Qianzhi Bio Technology Co Ltd [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Business combination related cost       482,144     $ 389,099
Business Combination Marketing Agreement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Business combination related cost       $ 2,415,000      
Percentage of gross proceeds of initial public offering   3.50%   3.50% 3.50%    
Percentage of service fee of total consideration payable   1.00%   1.00% 1.00%    
Forward Purchase Agreement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Prepaid forward purchase shares 500,000